Suchergebnisse - "Foppoli, Marco"

PubPharm (48)

1

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma : A Systematic Review

enthalten in: Cancers | 2023

von Steffanoni, S. | Calimeri, T. | Marktel, S. | +3

2

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

enthalten in: Blood advances | 2022

von Ferreri, A. | Angelillo, P. | Erbella, F. | +15

3

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Pesenti, G. | Foppoli, M. | Manca, D.

4

Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma

enthalten in: Expert opinion on therapeutic targets | 2021

von Calimeri, T. | Steffanoni, S. | Foppoli, M. | +2

5

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Pesenti, G. | Foppoli, M. | Manca, D.

6

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Pesenti, G. | Foppoli, M. | Manca, D.

7

A minimal physiologically based pharmacokinetic model for high-dose methotrexate

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Pesenti, G. | Foppoli, M. | Manca, D.

8

MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma : results from a prospective study

enthalten in: British journal of haematology | 2021

von Ferreri, A. | Calimeri, T. | Lopedote, P. | +31

9

A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma : safety and efficacy results of the "CARMEN" phase II trial

enthalten in: British journal of haematology | 2021

von Ferreri, A. | Cattaneo, C. | Lleshi, A. | +15

CommentIn: Br J Haematol. 2021 Jan;192(1):13-14. - PMID 33090470

10

A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma : safety and efficacy results of the “CARMEN” phase II trial

enthalten in: British Journal of Haematology | 2021

von Ferreri, A. | Cattaneo, C. | Lleshi, A. | +15

1
2
3
4
5
Nächster »
[5]